Genetic polymorphisms in age-related macular degeneration

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2740242

Methods for determining whether a patient is at increased risk of developing wet AMD or whether a patient has an increased likelihood of benefiting from treatment with a high-affinity anti- VEGF antibody.

L'invention porte sur des procédés pour déterminer si un patient présente un risque accru de développer une dégénérescence maculaire liée à l'âge humide ou si un patient a une probabilité accrue de bénéficier d'un traitement par un anticorps anti-VEGF à haute affinité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Genetic polymorphisms in age-related macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetic polymorphisms in age-related macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic polymorphisms in age-related macular degeneration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1798301

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.